Better outcomes for the older surgical patient trial (BOOST): protocol for a hybrid type 1 effectiveness-implementation trial of an embedded geriatric perioperative service within emergency and elective surgery in an Australian tertiary referral hospital Authors: Clarissa Sagi, Henry Logan, Erica Epstein, Elizabeth Holliday, Stephen Ridley Smith, Jenny Mackney, Christine L Paul, Suzanne Clark-Pitrolo, Donna Gillies, Christine J O’Neill Published: 2026 ABSTRACT AbstractIntroductionOlder patients admitted under surgical care have longer length of stay (LOS) and are at risk of functional decline, hospital-acquired complications and geriatric syndromes. Embedded specialist geriatrician models within surgical care teams can reduce length of stay and perioperative complications. Evidence gaps remain regarding the implementation of these models of care and their impact on patient outcomes. This study aims to measure hospital, patient and implementation outcomes of an embedded perioperative geriatric service in a large Australian tertiary referral hospital.Methods and analysisThis hybrid type 1 effectiveness-implementation trial involves four services (emergency general, elective general, urology and vascular surgery), with a predicted reach of >2000 patients over 24 months. The intervention consists of a proactive geriatrician-led service providing a comprehensive geriatric assessment and ongoing review during the acute admission. Service evaluation will be via (1) traditional hospital outcomes (primary outcome LOS); (2) implementation outcomes; and (3) patient reported outcomes across three 6 month phases: (1) prior to service implementation; (2) during service implementation and (3) continued service but without active implementation. Data analysis will include descriptive statistics of patient demographics, clinical characteristics and implementation outcomes; cost-effectiveness; univariate and multivariate analysis of outcomes against demographic and clinical characteristics and thematic analysis of qualitative data.Ethics and disseminationThis trial has been approved by the Hunter New England Research Ethics Committee (2024_ETH023259). The findings will be disseminated via peer-reviewed publications and conference presentations. The research team will facilitate adoption more broadly within the health service.Trial registration numberAustralian New Zealand Clinical Trials Registry (ACTRN12625000404426)Keywords: GERIATRIC MEDICINE; SURGERY; Aged; Delivery of Health Care, Integrated; Hospitalization STRENGTHS AND LIMITATIONS OF THIS STUDY Hybrid type 1 effectiveness-implementation design allows simultaneous evaluation of clinical and implementation outcomes. Hybrid type 1 effectiveness-implementation design allows simultaneous evaluation of clinical and implementation outcomes. Mixed-methods evaluation incorporates hospital metrics, implementation measures and patient-reported outcomes, addressing knowledge gaps in these areas. Mixed-methods evaluation incorporates hospital metrics, implementation measures and patient-reported outcomes, addressing knowledge gaps in these areas. Large projected sample (>2000 participants) across emergency and elective surgical cohorts enhances statistical power. Large projected sample (>2000 participants) across emergency and elective surgical cohorts enhances statistical power. Single site implementation and concurrent organisational initiatives may influence outcomes and limit generalisability of the findings. Single site implementation and concurrent organisational initiatives may influence outcomes and limit generalisability of the findings. The use of patient-reported outcome measures (PROMs) as indicators of functional status in follow-up may be subject to response and attrition bias, particularly among frailer patients. The use of patient-reported outcome measures (PROMs) as indicators of functional status in follow-up may be subject to response and attrition bias, particularly among frailer patients. Introduction The number of older patients being admitted under surgical services for both operative and non-operative care is increasing.1,3 Older patients can benefit from surgical intervention; however, adverse postoperative outcomes are more frequent in this population due to the combination of declining physiological reserve, multi-morbidity, multi-domain frailty and cognitive impairment.4,7 The presence of geriatric syndromes increases the risk of hospital-acquired complications, such as delirium, cognitive and functional decline, patient and carer distress, prolonged hospitalisation, institutionalisation and mortality.8 Australian hospital systems are experiencing organisational challenges and increased healthcare costs associated with increased length of stay (LOS), bed occupancy and readmissions.9 10 Existing reactive medical consultation is limited by conflicting responsibilities resulting in delayed reviews, poor continuity of care and variable expertise in geriatric medicine. With increasing medical complexity of acute surgical presentations,11 there is an urgent need to investigate integrated models of medical and surgical care in this patient group. Consensus guidelines recommend collaborative multidisciplinary models that embed geriatric medicine principles to improve patient and organisational outcomes.1,312 Geriatricians use comprehensive geriatric assessment (CGA) to assess medical, functional, psychological and social factors to develop a coordinated multi-disciplinary management plan.13 CGA models of care are well-established for older patients with hip fractures and have been evaluated in emergency general surgery, vascular surgery, elective oncology surgery, emergency and elective colorectal surgery and elective lumbar spine surgery.14,21 Studies support the use of CGA in the perioperative pathway in achieving reductions in length of hospital stay and postoperative complication rates.12 13 Geriatrician-led CGA in older emergency general surgery patients has been demonstrated to decrease median LOS by 3 to 4.4 days.22 23 Analysis of the UK National Emergency Laparotomy Audit (NELA) showed that postoperative geriatrician review was also associated with reduced mortality.24 25 Economic evaluation of services involving geriatricians in care of older emergency abdominal surgery patients reported reduced costs compared with standard care.22 25 26 Collaborative care of older surgical patients is also shown to improve patient and staff satisfaction.25 27 Evidence gaps remain regarding longer term patient functional outcomes and decision satisfaction and the impact of care models on older surgical patients receiving non-operative care. The objective of this study is to implement and evaluate an embedded geriatric perioperative service, addressing evidence gaps around implementation and longer-term patient outcomes. The results of this study will provide data to build a framework for other hospitals and health systems to implement similar services. Long-term patient outcome data will inform surgical decision making and health service resourcing and ensure that patient well-being remains at the heart of surgical care. Methods and analysis Study setting An embedded geriatric service will be implemented into the general surgical, urology and vascular teams at the John Hunter Hospital, Newcastle, New South Wales (NSW) Australia. A >800 bed tertiary referral hospital managing patients from the local metropolitan area also provides subspecialist care to residents of Hunter New England Local Health District (HNELHD), with a population of over 973 000 people, from a geographical area of 131 785 square kilometres. The service design was influenced by literature review,1722 23 28,32 systematic review33 and lived in-house experience of an existing successful orthogeriatric service.34 The service was further refined during a 6 month pilot of an embedded geriatric service within emergency general surgery. Key multidisciplinary stakeholders were involved in service design with a focus on sustainability of the service beyond the trial period. Written principles of co-management helped clarify surgeon and geriatrician roles and responsibilities. Study intervention The Geriatric Perioperative Service (GPS) consists of a geriatrician and clinical nurse consultant, providing a pro-active co-management service with daily rounds including CGA, inpatient review and perioperative optimisation from Monday to Friday. Surgical teams will remain primarily responsible for patient management and decision making. The GPS aims to review patients within 24 hours of admission (72 hours for weekend admissions) and provide a CGA including: Assessment and optimisation of co-morbidities and functional status. Assessment and optimisation of co-morbidities and functional status. Management of perioperative medications including appropriate decision making in the setting of polypharmacy. Management of perioperative medications including appropriate decision making in the setting of polypharmacy. Regular inpatient review including prevention, early identification and management of geriatric syndromes (delirium, frailty, falls, polypharmacy) and hospital acquired complications. Regular inpatient review including prevention, early identification and management of geriatric syndromes (delirium, frailty, falls, polypharmacy) and hospital acquired complications. Involvement in shared decision making, including assisting with prognostication and establishing goals of care or end of life care. Involvement in shared decision making, including assisting with prognostication and establishing goals of care or end of life care. Perioperative risk stratification and interpretation of risk scores for frail older people. Perioperative risk stratification and interpretation of risk scores for frail older people. Proactive goal setting and discharge planning which engages patients, carers and the multidisciplinary team. Proactive goal setting and discharge planning which engages patients, carers and the multidisciplinary team. For elective surgical patients screened as at high risk for perioperative morbidity and mortality, the geriatrician review will occur in the perioperative clinic, prior to surgical admission. The clinical service will be implemented with a focus on acceptability, fidelity and feasibility, ensuring that the service meets the specific context needs of each surgical admitting team, and will be sustainable beyond the trial period. Study design A hybrid type 1 effectiveness-implementation study design will be undertaken, prioritising evaluation of clinical effectiveness outcomes while concurrently examining implementation processes and contextual determinants influencing service integration and sustainability. The better outcomes for the older surgical patient trial (BOOST) trial will formally commence in February 2025, with staggered implementation across participating surgical services over a 24 month period (February 2025 to January 2027). The service will be introduced to a new surgical admitting service every 6 months to 2 years. The service will initially be introduced to emergency general surgery as baseline data collected within the Acute General Surgical Unit between August 2022 and February 2024 is already available from the prior pilot study. For all other surgical services (elective general, urology and vascular), the staggered design will allow a 6 month data collection period prior to the introduction of the GPS (baseline), followed by a 6 month intervention period of service implementation (intervention) and then a 6 month period of data collection post-active implementation but with continued GPS service. 6 month follow-up for patient-reported outcomes and 180 day clinical outcomes will extend data collection through to at least August 2027. Final post-data collection and consolidation phases are anticipated to occur between August and December 2027. A summary of the trial design is shown in figure 1. The clinical service will remain in place following the completion of the intervention phase but without associated data collection and analysis. While data collection occurs across defined baseline, intervention and continued-service phases, the GPS represents a permanent service redesign rather than a time-limited intervention. The staged design enables evaluation of implementation processes and early sustainability within real-world clinical practice. Study design. BOOST, better outcomes for the older surgical patient trial. The impact of the GPS will be assessed across three areas of measurement: (1) traditional service and clinical measures, (2) implementation and (3) patient reported outcomes (PROMs). Clinical data will be obtained via interrogation of the electronic medical record with cross-checking for accuracy. Datapoints will include patient demographics; clinical data (reason for admission, comorbidities and procedural data); geriatric risk factors (polypharmacy, clinical frailty scale,35 cognitive impairment via 4AT36 and malnutrition screening tool)37; length of stay, hospital acquired complications, rapid response calls and intensive care admissions, discharge destination; mortality (in hospital or days alive and out of hospital up to 180-days) and readmission data. Implementation will be guided and measured by the Consolidated Framework for Implementation Research (CFIR).38 During the baseline period, specific needs and context assessments will be undertaken and stakeholders (clinicians, allied health, nurses, administration and management) identified and engaged. The intervention phase will assess measures of service fidelity, penetration and resourcing with continuous quality improvement cycles aimed at tailoring the service to the specific context and addressing barriers. During the study period of continued service, measures of service fidelity and reach will be collected. Mixed-methods assessment of staff acceptability and exploration of facilitators and barriers will occur during each phase. The Theoretical Framework of Acceptability (TFA) Survey will be used in each of the three phases.39 Staff will be invited to complete surveys via a web-link or QR code. Free text feedback will be sought and interviews undertaken with key stakeholders, primarily focusing on identifying barriers and facilitators to implementation as well as tailoring the service to need. Staff surveys are presented in online supplemental material-appendix 1. Patients admitted during the intervention period will be invited to complete PROMs prior to and at 1 month and 6 months following discharge. The study will be introduced to patients with both verbal and written information, either in the perioperative clinic or during their hospital admission. Surveys include EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L),40 patient reported outcomes measurement information system – 29+2 (PROMIS 29+2),41 decision regret scale,42 and Australian hospital patient experience question set (AHPEQS),43 figure 2. Surveys can be completed on paper, telephone or via web-link, in line with patient preferences. In the event of a survey non-response, a telephone reminder will be made by a member of the study team 3 weeks after the initial survey was sent. A maximum of three attempts to contact patients at each time point will be undertaken. Survey Schedule for Patients during Intervention Phase. Only patients with planned surgical admissions will be invited to complete initial surveys. AHPEQS, Australian Hospital Patient Experience Question Set; EQ-5D-5L, EuroQol 5-Dimension 5-Level questionnaire; PROMIS 29+2, patient reported outcomes measurement information system 29+2. Clinical outcome data are extracted from the electronic medical record by designated research personnel and cross-checked for accuracy. PROMs are administered by members of the study team independent of routine clinical documentation processes. Implementation surveys are distributed electronically, and qualitative interviews are conducted by investigators not directly involved in management of participants. Research and clinical team framework is outlined in Author Contributions table. Outcome measures The primary outcome measures of the study will be as follows: (1) hospital length of stay (LOS), compared across the three phases of the study, and (2) intervention acceptability. We acknowledge that LOS may be influenced by system-level factors in addition to patient-level clinical factors. Accordingly, LOS findings will be interpreted alongside secondary effectiveness outcome measures including hospital readmission; in hospital, 30-day and 180-day mortality; days alive and out of hospital; hospital acquired complications, unplanned ICU admissions and cost-effectiveness. Secondary implementation outcomes will be assessed under CFIR with a focus on intervention fidelity, feasibility, adaptability and sustainability of the service. Patient satisfaction following admission will be measured using AHPEQS. Self-reported PROMs and decision regret scales will be collected, figure 2. Inclusion criteria Eligible patients will be aged 65 years or older, or 45 years and older if Aboriginal and/or Torres Strait Islander, and requiring admission to the relevant surgical services, with an anticipated hospital stay of greater than 48 hours. Patients meeting eligibility criteria will be identified from electronic medical records. For emergency admissions, the daily admission list will be cross-checked by the GPS team to identify eligible patients. Elective admission patients will be identified from screening in the perioperative clinic, including referrals to the high-risk perioperative clinic. Screening will be completed by both nurses and geriatricians. The index admission will define the study arm during the study period. All patients meeting eligibility during each study period will be included in the sample populations. Exclusion criteria Participants will be excluded if they are admitted for less than 48 hours or are jointly admitted with a medical service. Patients will be excluded from the PROMs component of the study if they have insufficient English literacy or lack the cognitive capacity to complete the surveys (as assessed during CGA). Patients will still be able to participate if a surrogate is able to complete surveys on their behalf: the use of a surrogate and the reason for this will be noted. The use of surrogates in this study is justified as the rate of cognitive decline is high and excluding this group will be likely to adversely influence the generalisability of the findings.44 Consent The study involves a three-part consent process Waiver of consent for clinical intervention: The GPS represents a service-level quality improvement initiative that will be integrated into routine care. The service aims to deliver care consistent with best-practice guidelines and NSW Agency of Clinical Innovation (ACI) recommendations.45 Waiver of consent for clinical intervention: The GPS represents a service-level quality improvement initiative that will be integrated into routine care. The service aims to deliver care consistent with best-practice guidelines and NSW Agency of Clinical Innovation (ACI) recommendations.45 Implied consent for surveys (PROMs and staff acceptability): Patients will receive a participant information and consent form via the pre-admission clinic or as soon as feasible during the surgical admission, online supplemental material-appendix 2. Patients can preference the mode of delivery of surveys (email, phone or mail) and opt out of the survey component of the study. As part of routine clinical care, the geriatrician will complete a cognitive and capacity assessment to determine whether a patient is able to provide consent. If a patient is deemed unable to consent, their carer will be approached in person or by telephone to discuss participation. Completion of the PROMs will be taken as implied consent.Staff acceptability surveys will be voluntary, and study information will be embedded in the survey introduction. Survey completion will imply study consent. Implied consent for surveys (PROMs and staff acceptability): Patients will receive a participant information and consent form via the pre-admission clinic or as soon as feasible during the surgical admission, online supplemental material-appendix 2. Patients can preference the mode of delivery of surveys (email, phone or mail) and opt out of the survey component of the study. As part of routine clinical care, the geriatrician will complete a cognitive and capacity assessment to determine whether a patient is able to provide consent. If a patient is deemed unable to consent, their carer will be approached in person or by telephone to discuss participation. Completion of the PROMs will be taken as implied consent. Staff acceptability surveys will be voluntary, and study information will be embedded in the survey introduction. Survey completion will imply study consent. Written consent for interviews: Staff can nominate to be involved in interviews at the time electronic survey completion. Written informed consent will be obtained for all qualitative interviews of staff. Written consent for interviews: Staff can nominate to be involved in interviews at the time electronic survey completion. Written informed consent will be obtained for all qualitative interviews of staff. Data management and confidentiality All research data will be collected and managed using the REDCap electronic data system hosted at HNELHD.46 Paper-based study material will be stored in locked cabinets prior to being shredded after electronic data entry is complete. Interviews will be audio recorded, transcribed, stored and managed electronically using NVivo 12 (QSR International, Melbourne, Australia). All electronic data will be housed on secure servers in password protected files accessed only with two-factor authentication. An audit of trial management including data verification is planned within the first 12 months of the trial. Data analysis plan and sample size calculations Descriptive statistics will summarise patient demographics, clinical characteristics (including frailty and delirium), and hospital outcome measures (length of stay, mortality, readmissions) across baseline, intervention and continued-service periods. Implementation data (TFA acceptability, fidelity and reach) will be summarised descriptively across periods. The primary outcome (LOS) will be analysed using a generalised linear model (GLM) with an appropriate distribution and link, including fixed effects for trial phase (baseline, intervention and continued service), clinical service, calendar time, and potentially confounding demographic and clinical covariates. Cluster-robust standard errors, obtained using small-sample wild cluster bootstrap at the service level,47,49 will be used for inference. Secondary outcomes will be analysed using appropriate GLMs with the same fixed-effect structure and cluster-robust inference. Service-specific intervention effects will be estimated separately. Statistical significance will be assessed at the 0.05 level, with emphasis on effect sizes and CIs. For missing data, complete case analysis will be the primary approach. For PROMs—where 20–30% attrition is anticipated—multiple imputation under a missing at random assumption will be undertaken as a sensitivity analysis. Imputation models will include covariates associated with PROM missingness, observed PROM values and other relevant clinical outcomes. PROMs will not be imputed after death, and survivor denominators will be reported explicitly. Cost-effectiveness will be assessed using both QALYs and hospital case-mix coding data comparing baseline, intervention and continued service phases. Qualitative thematic analysis will be performed using interviews and other qualitative data from group discussions. Based on hospital admissions data, a projected sample size of 2100 patients is estimated over 24 months. Previous studies1722 23 28,32 (and our own pilot data)33 report a mean length of stay of 10.5 days (SD=16 days) without an embedded geriatric service and 7.5 days (SD=10 days) after embedding the service. For this study, we conservatively estimate a mean LOS reduction of 2.5 days and a mortality rate of 10%. Assuming a normal distribution, this sample will provide >91% power to detect a difference of 2.5 days in mean LOS at 0.05 (two-sided) significance based on a two-sample t-test allowing unequal variances. Acknowledging the possibility of a right-skewed response distribution for LOS, power will be slightly lower but is anticipated to remain >80% for effect estimates in the range of 2.5–3 days, as observed in previous studies.1722 23 28,33 Patient and public involvement statement The study team includes a trained consumer who has been involved in protocol development. A 12 month pilot study of the GPS in emergency general surgery was undertaken in 2023–2024. This included the use of PROMs for the 12 months following admission and surveyed patients on the acceptability of the tools. Based on this data, survey timeframes, tools and method of survey collection were refined. Approaches to follow-up of survey non-responders were enhanced. Intervention delivery and trial design was also informed by information gathered from patients and carers during the pilot phase. Ethics and dissemination The trial was approved by the Hunter New England Human Research Ethics Committee in December 2024 (2024ETH02359) and registered with the University of Newcastle Research Integrity Unit (R-2025-0016). The trial was registered with Australian New Zealand Clinical Trials Registry (ACTRN12625000404426) in May 2025. Data will be reported in line with the Standards of QUality Improvement Reporting Excellence (SQUIRE) guidelines.50 Trial findings will be disseminated via peer reviewed publications and local, national and international academic conference presentations targeting surgical, perioperative and geriatrics professionals. Participants can request a copy of the results of the study team, and a plain language summary of the trial outcomes will be made publicly available. Resourcing The study is funded by a grant from the Translational Research Grant Scheme of the HCF Research Foundation (2024), administered by the University of Newcastle (G2301517). This funding supports research personnel, data management and evaluation activities. The clinical staffing of the Geriatric Perioperative Service (geriatrician and clinical nurse consultant positions) is supported through in-kind funding from John Hunter Hospital as a permanent quality enhancement initiative within Surgical Services. The service has been incorporated into routine hospital operations and is intended to continue beyond the formal research evaluation period. Supplementary material Acknowledgements Michael Boyle, Marcus Handmer, Zoheb Williams, Jon Gani, Radhika Rice, Lisa Doyle, Ashleigh Phillips, Lesley Barron, Natalie Lott, Emma Weick, Sean Klower, Kaylan Bower. Footnotes Funding: This work was supported by the Translational Research Grant Scheme of the HCF Research Foundation (2024), administered by the University of Newcastle (grant number G2301517). Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (https://doi.org/10.1136/bmjopen-2025-114825). Provenance and peer review: Not commissioned; externally peer reviewed. Patient consent for publication: Not applicable. Patient and public involvement: Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details. References Supplementary Materials